News
FUSE-AI with international ambitions
On June 27, 2024, Matthias Steffen and Juri Rohde were guests at Oost NL, an economic development agency in the eastern Netherlands. FUSE-AI intends to operate internationally and has become aware of Oost-NL in this context.
Finalists in two prestigious AI competitions
With our AI solution “Prostate.Carcinoma.ai”, we have reached the final round of two prestigious competitions: the AI Innovation 2024 and the KPMG Venture Champion Award. The AI Innovation Award, presented by the AI Federal Association Germany, recognizes pioneering achievements of companies. The focus is not only on the development of the company's own AI solution but also on its sustainable impact on the industry and society overall.
Successful cooperation - Innovation Day at Aarau Cantonal Hospital
Lots of impetus for the use of AI in medicine at the presentation
On May 29, the ‘Day of Innovation and Research’ took place for the second time at the Kantonsspital Aarau KSA, Switzerland - focusing this time on the topic of “Artificial Intelligence in Medicine”.
Entering the US market - FUSE-AI in New York and San Francisco
FUSE-AI and nine German startups participated in the German American Chamber of Commerce (GACC) to meet investors at pitches in New York and San Francisco targeted to support our entry into the US market.
Annual surveillance audit EN ISO 13485
The mandatory audit by the Notified Body BSI takes place on June 5 and 6. Our quality management system as a medical device manufacturer for AI-based software is verified each year.
Matthias Steffen discusses the future of secure data usage at the AnoSiDat Congress
At the congress 'Anonymization for Secure Data Usage', leading branches heads came together in Lübeck from April 16th to 17th, 2024, to present and discuss the latest findings and innovative approaches to data anonymization.
T-Systems is now our official partner in Switzerland and is offering Prostate.Carcinoma.ai as on-premise solution
Radiology clinics and practices in Switzerland can now obtain the AI-based software "Prostate.Carcinoma.ai" from the Hamburg-based e-health company FUSE-AI centrally through T-Systems, which assists radiologists in analyzing prostate MR images.
Great Feedback at the ECR
We're thrilled to have experienced such a great turnout and interest at the ECR in Vienna last week! Once again, it's been confirmed that we're on the right track. Our major advantage is that we offer "Prostate.Carcinoma.ai" to our customers as fully integratable software.
FUSE-AI was represented at 4YFN as part of Mobile World Congress
FUSE-AI was represented at 4YFN in mid-February in Barcelona. 4YFN is all about promoting start-ups, giving them a stage to shine, connecting with investors, showcasing their groundbreaking ideas and providing plenty of opportunities for intensive networking. All this took place in the lively atmosphere of the Mobile World Congress (MWC).
LLM and robotics: Knowledge nuggets written for our readers
In the field of machine control using Large Language Models (LLMs), overcoming technical obstacles requires innovative solutions on various levels. Researchers and developers are tackling each challenge with determination, devising strategies to enhance the capabilities of LLMs in effectively controlling machines.